| For: | Bistagnino F, Pizzi D, Mantovani F, Antonino JR, Tovani-Palone MR. Long COVID and gut candidiasis: What is the existing relationship? World J Gastroenterol 2024; 30(37): 4104-4114 [PMID: 39474404 DOI: 10.3748/wjg.v30.i37.4104] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i37/4104.htm |
| Number | Citing Articles |
| 1 |
Raphaela I. Lau, Qi Su, Siew C. Ng. Long COVID and gut microbiome: insights into pathogenesis and therapeutics. Gut Microbes 2025; 17(1) doi: 10.1080/19490976.2025.2457495
|
| 2 |
Keda Chen, Zhiyi Wang, Jiaxuan Li, Yutong Xu, Siyi Gu, Hongyu Li, Jianhua Li, Yanjun Zhang, Naihui Mao. Chronic inflammation in Long COVID relationship to autoimmune diseases. Autoimmunity Reviews 2025; 24(10): 103882 doi: 10.1016/j.autrev.2025.103882
|
| 3 |
Andreas Stallmach, Peter Layer, Katrin Katzer, Philipp A. Reuken. Lessons from irritable bowel syndrome: potential for understanding and managing post-COVID. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1717324
|
| 4 |
Filippo Bistagnino, Arunkumar Subramanian, Marcos Roberto Tovani-Palone. Navigating the (Post-) Pandemic Landscape: An Analysis of COVID-19’s Current Status and Future Implications. Disaster Medicine and Public Health Preparedness 2025; 19 doi: 10.1017/dmp.2025.10
|
| 5 |
Jiaxing Liu, Mei Han, Fan Yang, Shuo Gao, Wanqing Zhou, Han Shen, Xiaoli Cao, Yan Zhang. Yeast infections in sterile body fluids: species distribution, antifungal susceptibility, and cross-cutting risk factors for fungemia, sepsis, and mortality (2019–2023). Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1773098
|